tiprankstipranks
Trending News
More News >
Traws Pharma (TRAW)
NASDAQ:TRAW
US Market

Traws Pharma (TRAW) Financial Statements

Compare
1,858 Followers

Traws Pharma Financial Overview

Traws Pharma's market cap is currently $14.14M. The company's EPS TTM is $-0.34; its P/E ratio is 0.07; Traws Pharma is scheduled to report earnings on November 13, 2025, and the estimated EPS forecast is $-1.91. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 226.00K$ 226.00K$ 226.00K$ 226.00K$ 231.00K
Gross Profit$ 214.00K$ 226.00K$ 226.00K$ 226.00K$ 231.00K
Operating Income$ -49.35M$ -20.30M$ -19.63M$ -16.50M$ -24.99M
EBITDA$ -166.51M$ -20.28M$ -19.61M$ -16.48M$ -24.98M
Net Income$ -54.67M$ -18.95M$ -18.96M$ -16.16M$ -25.16M
Balance Sheet
Cash & Short-Term Investments$ 21.34M$ 20.82M$ 38.76M$ 55.07M$ 19.02M
Total Assets$ 24.96M$ 22.68M$ 39.37M$ 55.48M$ 19.99M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -21.34M$ -20.82M$ -38.76M$ -55.07M$ -19.02M
Total Liabilities$ 56.59M$ 12.01M$ 11.06M$ 9.36M$ 13.81M
Stockholders' Equity$ -31.63M$ 10.67M$ 28.31M$ 46.12M$ 6.17M
Cash Flow
Free Cash Flow$ -29.79M$ -17.95M$ -16.29M$ -19.49M$ -23.09M
Operating Cash Flow$ -29.79M$ -17.93M$ -16.29M$ -19.49M$ -23.07M
Investing Cash Flow$ -3.65M$ -14.00K$ 0.00$ 0.00$ -15.00K
Financing Cash Flow$ 33.98M$ 0.00$ 0.00$ 55.56M$ 19.36M
Currency in USD

Traws Pharma Earnings and Revenue History

Traws Pharma Debt to Assets

Traws Pharma Cash Flow

Traws Pharma Forecast EPS vs Actual EPS